Back to top
more

Inotiv (NOTV)

(Real Time Quote from BATS)

$4.05 USD

4.05
97,307

-0.24 (-5.59%)

Updated Apr 26, 2024 11:55 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 252)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for NOTV

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Inotiv, Inc falls in the month of September.

All items in Millions except Per Share data.

9/30/2023 9/30/2022 9/30/2021 9/30/2020 9/30/2019
Assets          
Cash & Equivalents 35 19 157 1 1
Receivables 87 100 28 11 7
Notes Receivable 0 0 0 0 0
Inventories 56 71 1 1 1
Other Current Assets 35 42 3 2 4
Total Current Assets 214 233 189 15 12
Net Property & Equipment 191 186 48 29 23
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 403 504 76 9 6
Deposits & Other Assets 10 8 0 0 0
Total Assets 857 963 322 62 42
Liabilities & Shareholders Equity 9/30/2023 9/30/2022 9/30/2021 9/30/2020 9/30/2019
Notes Payable 0 0 0 0 0
Accounts Payable 33 29 6 3 5
Current Portion Long-Term Debt 8 23 11 9 3
Current Portion Capital Leases 0 0 0 5 0
Accrued Expenses 26 36 9 3 3
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 56 69 27 12 7
Total Current Liabilities 132 164 55 32 17
Mortgages 0 0 0 0 0
Deferred Taxes/Income 50 77 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 370 331 154 19 14
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 6 6 0 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 588 603 217 54 31
Shareholders Equity 9/30/2023 9/30/2022 9/30/2021 9/30/2020 9/30/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 6 6 4 3 3
Capital Surplus 716 708 112 27 25
Retained Earnings -453 -348 -11 -22 -17
Other Equity 0 -6 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 268 360 105 8 11
Total Liabilities & Shareholder's Equity 857 963 322 62 42
Total Common Equity 268 360 105 8 11
Shares Outstanding 25.70 25.50 15.90 10.90 10.50
Book Value Per Share 10.45 14.11 6.61 0.69 1.02

Fiscal Year End for Inotiv, Inc falls in the month of September.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 22 35 22 25
Receivables NA 90 87 83 74
Notes Receivable NA 0 0 0 0
Inventories NA 51 56 54 64
Other Current Assets NA 28 35 44 48
Total Current Assets NA 191 214 203 211
Net Property & Equipment NA 192 191 189 189
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 395 403 412 421
Deposits & Other Assets NA 11 10 9 7
Total Assets NA 836 857 855 869
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 31 33 31 30
Current Portion Long-Term Debt NA 8 8 4 4
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 23 26 23 31
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 36 56 53 57
Total Current Liabilities NA 109 132 121 132
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 45 50 49 55
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 371 370 372 0
Non-Current Capital Leases NA 0 0 0 370
Other Non-Current Liabilities NA 6 6 6
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 581 588 580 596
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 6 6 7 6
Capital Surplus NA 715 716 714 712
Retained Earnings NA -469 -453 -444 -445
Other Equity NA 2 0 0 -1
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 254 268 275 273
Total Liabilities & Shareholder's Equity NA 836 857 855 869
Total Common Equity 0 254 268 275 273
Shares Outstanding 25.70 25.70 25.70 25.70 25.60
Book Value Per Share 0.00 9.89 10.45 10.71 10.65